Biotech Stocks Shine: Novo Nordisk and IDEAYA Among Top Gainers After FDA Approval

Novo Nordisk stock jumped after FDA approved its oral obesity drug. IDEAYA, Neumora, and others also posted strong biotech sector gains.

EcoPulse24 News Desk By EcoPulse24 News Desk Published: 12/23/2025, 17:34:00 UTC Updated: 1/17/2026, 06:53:18 UTC
Share
Biotech Stocks Shine: Novo Nordisk and IDEAYA Among Top Gainers After FDA Approval
Biotech Stocks Shine: Novo Nordisk and IDEAYA Among Top

Dubai, United Arab Emirates – Healthcare and biotechnology sector stocks saw significant movement in after-hours trading on Monday, December 23, 2025, with several companies posting strong gains.

Novo Nordisk Leads Gains with Historic FDA Approval

Novo Nordisk (NVO) led the market with an exceptional 9.48% jump to $52.66, adding $4.56 to its value. This surge followed the US Food and Drug Administration's (FDA) approval of the oral Wegovy pill, the first GLP-1 class oral drug for obesity treatment in the US.

The medication is intended for use alongside a low-calorie diet and increased physical activity to help adults with obesity or overweight issues accompanied by weight-related medical conditions. Notably, Wegovy also secured approval for reducing the risk of major adverse cardiovascular events, including death, heart attacks, and strokes in adults with cardiovascular disease.

Other Companies Post Notable Gains

IDEAYA Biosciences (IDYA) rose 6.49% to $37.81 in extended trading. The company recently announced full enrollment of 435 patients in its phase 2/3 OptimUM-02 clinical trial evaluating darovasertib in combination with Pfizer's crizotinib for metastatic uveal melanoma. IDEAYA expects to report progression-free survival data in Q1 2026.

Neumora Therapeutics (NMRA) advanced 16.02% to $2.10, despite no specific company news, indicating broad investor interest in the sector.

Healthcare Triangle (HCTI) climbed 6.72% to $1.43. On December 10, the company announced a preliminary agreement with Teyame AI LLC as part of its plan to acquire Spanish AI firms Teyame 360 SL and Datono Mediacion SL, both specializing in customer experience AI solutions.

Other Biotech Firms in the Spotlight

BioRestorative Therapies (BRTX) gained 6.90% to $1.24, while RenovoRx (RNXT) added 4.44% to reach $0.94. Alphatec Holdings (ATEC), specializing in spine surgery technology, posted a modest 2.80% gain to $21.28.

Source: RTTNews, December 23, 2025

Disclaimer: The information in this report is sourced from financial news outlets and does not constitute investment advice. Investors are advised to conduct their own research and consult qualified financial advisors before making any investment decisions.

Sources & References
RTTNews
Editorial Note
Edited & Reviewed by the Ecopulse Editorial Board 1/17/2026, 06:53:18 UTC
Disclaimer
The content provided by EcoPulse24 is for informational and educational purposes only and does not constitute financial, investment, legal, tax, or any other type of professional advice. All opinions expressed are those of the EcoPulse24 editorial team and do not represent the views of any third-party data providers or institutions. Investments involve risk, including the possible loss of principal. Past performance is no guarantee of future results. Readers should conduct their own due diligence and consult qualified professional advisors before making any investment decisions. EcoPulse24 and its affiliates, editors, and contributors shall not be held liable for any errors, omissions, or any losses, injuries, or damages arising from the use of this information.
Please review the Terms & Conditions.

© 2025 EcoPulse24. All rights reserved.